Wall Street investors pour money into developing new psychedelic treatments for mental illnesses; extreme temperature fluctuations around the country can pose health risks; Moderna and Merck's combination skin cancer treatment receives breakthrough designation from the FDA.
Read More
FDA Hits 4 Firms With Civil Money Complaints Over Unauthorized Tobacco Products
February 22nd 2023The civil money complaints, which carry a maximum penalty of $19,192 for a single violation, are intended to hold tobacco companies accountable for selling e-liquids—or vape juice—without FDA approval.
Read More
Merck’s COVID-19 pill has been shown to not be successful against household infection risk; the government plans to allow states to use Medicaid funds for prison drug treatment and other services; Ozempic, used to treat type 2 diabetes, is in short supply because it’s being sought for weight loss.
Read More
Social Security and Medicare spending could double by 2023; FDA panel experts want naloxone to be available over the counter after the drug information is revised; Moderna announced its COVID-19 vaccines will stay free, and the Biden administration might keep tests and treatments free for the uninsured.
Read More
Some communities will use COVID relief money to pay medical debt; residents living near train car derailment site in Ohio are worried about toxic chemical health effects; following medical guidelines point by point would create impossibly long workdays for providers, studies are pointing out.
Read More
Dr Linda D. Bradley Highlights Disparities in Diagnosis, Treatment for Endometriosis
February 15th 2023Women of color have a longer journey to diagnosis for endometriosis and uterine fibroids, have fewer resources to access care, and receive different treatments than White women, said Linda D. Bradley, MD, of Cleveland Clinic.
Read More
Improving Quality of Life for Patients With Atopic Dermatitis
February 14th 2023By following FDA treatment guidelines, care for patients with atopic dermatitis (AD) is not typically affected by step therapy, quantity limits, or prior authorization, explained Jerry Bagel, MD, director of the Eczema Treatment Center of New Jersey.
Read More
HHS wants to require nursing homes to disclose more ownership and management information; privacy advocates warn that mental health data can legally be sold from certain platforms not covered by the Health Insurance Portability and Accountability Act; the FDA won’t review Soligenix’s cancer drug proposal because of an insufficient application.
Read More
China’s angry reaction after spy balloon retrieval rouses drug supply chain anxiety; after allegedly overcharging California’s Medi-Cal program, managed care company Centene will pay millions in a settlement; major drug companies are chasing new pharma deals amidst dropping patent exclusivity.
Read More
Biden’s State of the Union (SOTU) address emphasized drug access for those on Medicare, the Cancer Moonshot, and more; HIV diagnoses are increasing in Washington, DC, from missed wellness visits and preventive visits upended during the start of COVID-19; California online women’s pharmacy The Pill Club will pay $18.3 million in Medicaid fraud settlement with California.
Read More
CVS Health Corp. is nearing a $10.5 billion deal to take on Oak Street Health Inc.; an innovative cystic fibrosis drug that can lengthen life expectancy for patients is blocked by high costs and unavailability in low-income countries; New York City will end the COVID-19 vaccine mandate for city workers.
Read More
Dr Lucio Gordan Outlines the Treatment Paradigm for KRAS-Positive NSCLC
February 6th 2023Being able to treat patients with non–small cell lung cancer (NSCLC) and a KRAS mutation with sotorasib has been exciting, and now there’s another drug available with the approval of adagrasib at the end of 2022, explained Lucio Gordan, MD, of Florida Cancer Specialists & Research Institute.
Read More
What We’re Reading: Child RSV Shot Disparities; Hospital Transparency Compliance; Abortion Pill Bans
February 6th 2023A pediatric shot for respiratory syncytial virus (RSV) may not be covered as a free routine vaccine; hospitals fail to comply with payment transparency rules; the fate of abortion pills is in the hands of conservative judges
Read More
What We’re Reading: Eyedrops Recalled; Inaccessible Weight Loss Drugs; Doctor, GOP Governor Spar
February 3rd 2023CDC warns against EzriCare Artificial Tears, which were recalled by the manufacturer; certain weight loss drugs not covered by most payers; Mississippi's Republican governor denies being privately in support of Medicaid expansion.
Read More
Merck & Co. and Eli Lilly & Co. report sales loss for COVID-19 treatments; Republican state attorneys general tell CVS and Walgreens that mailing mifepristone might break the law; exposure to air pollution over time is associated with a rise in incidence of depression and anxiety.
Read More
Pharmaceutical companies will not refund prepayments made by global organization Gavi for COVID-19 vaccines it no longer needs; following the countrywide baby formula shortage of 2022, the FDA looks to consolidate food division leadership; a province in Canada starts a 3-year drug decriminalization program to try to reduce drug overdose deaths.
Read More